Literature DB >> 24513499

Comorbidity and its relevance on general hospital based mortality in major depressive disorder: a naturalistic 12-year follow-up in general hospital admissions.

Dieter Schoepf1, Hardeep Uppal2, Rahul Potluri3, Suresh Chandran4, Reinhard Heun5.   

Abstract

Major depressive disorder (MDD) is associated with physical comorbidity, but the risk factors of general hospital-based mortality are unclear. Consequently, we investigated whether the burden of comorbidity and its relevance on in-hospital death differs between patients with and without MDD in a 12-year follow-up in general hospital admissions. During 1 January 2000 and 30 June 2012, 9604 MDD patients were admitted to three General Manchester Hospitals. All comorbidities with a prevalence ≥1% were compared with those of 96,040 age-gender matched hospital controls. Risk factors of in-hospital death were identified using multivariate logistic regression analyses. Crude hospital-based mortality rates within the period under observation were 997/9604 (10.4%) in MDD patients and 8495/96,040 (8.8%) in controls. MDD patients compared to controls had a substantial higher burden of comorbidity. The highest comorbidities included hypertension, asthma, and anxiety disorders. Subsequently, twenty-six other diseases were disproportionally increased, many of them linked to chronic lung diseases and to diabetes. In deceased MDD patients, chronic obstructive pulmonary disease and type-2 diabetes mellitus were the most common comorbidities, contributing to 18.6% and 17.1% of deaths. Furthermore, fifteen physical diseases contributed to in-hospital death in the MDD population. However, there were no significant differences in their impact on mortality compared to controls in multivariate logistic regression analyses. Thus in one of the largest samples of MDD patients in general hospitals, MDD patients have a substantial higher burden of comorbidity compared to controls, but they succumb to the same physical diseases as their age-gender matched peers without MDD.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Major depressive disorder; Mortality; Physical comorbidity; Public health; Risk factors

Mesh:

Year:  2014        PMID: 24513499     DOI: 10.1016/j.jpsychires.2014.01.010

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  6 in total

1.  Anxiety disorders and physical comorbidity: increased prevalence but reduced relevance of specific risk factors for hospital-based mortality during a 12.5-year observation period in general hospital admissions.

Authors:  Dieter Schoepf; Reinhard Heun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-12-04       Impact factor: 5.270

2.  Comorbidities in the diseasome are more apparent than real: What Bayesian filtering reveals about the comorbidities of depression.

Authors:  Peter Marx; Peter Antal; Bence Bolgar; Gyorgy Bagdy; Bill Deakin; Gabriella Juhasz
Journal:  PLoS Comput Biol       Date:  2017-06-23       Impact factor: 4.475

3.  Trends in the prevalence of depression in hospitalized patients with type 2 diabetes in Spain: analysis of hospital discharge data from 2001 to 2011.

Authors:  Ana Lopez-de-Andrés; Ma Isabel Jiménez-Trujillo; Valentín Hernández-Barrera; José Ma de Miguel-Yanes; Manuel Méndez-Bailón; Napoleón Perez-Farinos; Carmen de Burgos Lunar; Juan Cárdenas-Valladolid; Miguel Ángel Salinero-Fort; Rodrigo Jiménez-García; Pilar Carrasco-Garrido
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

4.  Effects of Comorbidities on Asthma Hospitalization and Mortality Rates: A Systematic Review.

Authors:  Masoud Mahdavian; Blake H Power; Shabnam Asghari; Jordan C Pike
Journal:  Can Respir J       Date:  2018-10-01       Impact factor: 2.409

5.  The anti-depressant effects of a novel PDE4 inhibitor derived from resveratrol.

Authors:  Yingcong Yu; Jinhui Wang; Xianfeng Huang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

6.  Hospital healthcare utilizers with medical and psychiatric claims in the Netherlands: a nationwide study.

Authors:  Maarten van Schijndel; Luc Jansen; Jan Busschbach; Jeroen van Waarde; Andre Wierdsma; Henning Tiemeier
Journal:  BMC Health Serv Res       Date:  2022-04-11       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.